While the spotlight shines brightly on Wegovy vs
Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat
Weight loss outcomes : Semaglutide at the doses used for weight management (Wegovy, 2.4 mg weekly) has produced average weight loss of 15-17% of body weight over 68 weeks in clinical trials (STEP program)
If an expense is tax-deductible, you can subtract the cost of your expense from your taxable income when filing your annual tax return
However, common side effects like nausea, fatigue, and dizziness may overlap with existing MS symptoms, requiring careful monitoring by healthcare providers
By the numbers: GLP-1 weekly injections have soared in popularity over the past few years, with 1 in 8 Americans reporting taking the drug in some form, according to KFF